Literature DB >> 33355812

COVID-19 and Methylene Blue.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33355812      PMCID： PMC7918388          DOI： 10.21470/1678-9741-2020-0462

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN： 0102-7638


× No keyword cloud information.
  3 in total

1.  Evidence of Protective Effect of Hydroxychloroquine on COVID-19.

Authors:  Beuy Joob; Viroj Wiwanitkit
Journal:  J Rheumatol       Date:  2020-05-25       Impact factor: 4.666

2.  Convalescent plasma therapy in the treatment of COVID-19: Some considerations: Correspondence.

Authors:  Viroj Wiwanitkit
Journal:  Int J Surg       Date:  2020-06-22       Impact factor: 6.071

3.  COVID-19 should be a methylene blue "promoter".

Authors:  Paulo Roberto B Evora
Journal:  Braz J Cardiovasc Surg       Date:  2020-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.